Bioequivalence of Saxagliptin/Metformin Immediate Release (IR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin IR Tablets in Healthy Adult Subjects

被引：0
|
作者：
Vijay V. Upreti
Chi-Fung Keung
David W. Boulton
Ming Chang
Li Li
Angela Tang
Bonnie C. Hsiang
Donette Quamina-Edghill
Ernst U. Frevert
Frank P. LaCreta
机构：
[1] Discovery Medicine and Clinical Pharmacology,
[2] Bristol-Myers Squibb Company (BMS),undefined
[3] Global Biometric Sciences,undefined
[4] BMS,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Metformin; Saxagliptin; Immediate Release; Bioequivalence Study; Study Drug Administration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 374
页数：9
相关论文
共 50 条
  • [41] TREATMENT OF TYPE 2 DIABETES IN COLOMBIA: ECONOMIC EVALUATION OF SAXAGLIPTIN/METFORMIN EXTENDED-RELEASE (XR) FIXED-DOSE COMBINATION (FDC)
    Elgart, J. F.
    Prestes, M.
    Gonzalez, L.
    Garrido Lecca, S.
    Aiello, E.
    Jimenez, C.
    Gagliardino, J. J.
    VALUE IN HEALTH, 2014, 17 (03) : A248 - A248
  • [42] Relative bioavailability and pharmacokinetic comparison of a fixed-dose combination tablet of mosapride, pancreatin, and simethicone relative to single-component mosapride tablets in healthy Mexican subjects
    Camarillo Cardenas, Karen Paola
    Garcia Gonzalez, Jessica
    Arguelles Tello, Federico Alberto
    Ocampo Ramirez, Jorge Arturo
    Moreno Hernandez, Jose Belisario
    Mohan Pendela, Murali
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (02) : 427 - 435
  • [43] Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin - Randomized, single-blind, three-period crossover study in healthy subjects
    Hoelscher, David
    Chu, Pei-Ling
    Lyness, William
    CLINICAL DRUG INVESTIGATION, 2008, 28 (09) : 573 - 582
  • [44] Design of Experiments for Critical Material Attributes Assessment of Linagliptin and Metformin Fixed-dose Combination Tablets
    Kim, Kang Min
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2021, 55 (03) : 701 - 708
  • [45] Population Pharmacokinetic Modeling and Noncompartmental Analysis Demonstrated Bioequivalence Between Metformin Component of Metformin/Vildagliptin Fixed-Dose Combination Products and Metformin Immediate-Release Tablet Sourced From Various Countries
    Chitnis, Shripad D.
    Han, Yi
    Yamaguchi, Masayuki
    Mita, Sachiko
    Zhao, Rong
    Sunkara, Gangadhar
    Kulmatycki, Kenneth
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (01): : 40 - 51
  • [46] AN ASSESSMENT OF THE PHARMACOKINETICS OF A LOBEGLITAZONE/METFORMIN FIXED-DOSE COMBINATION TABLET IN HEALTHY SUBJECTS.
    Kim, S-Y
    Jeon, J-Y
    Lee, S.
    Park, S-J
    Kim, M-G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S69 - S70
  • [47] Bioequivalence Evaluation Between Acarbose and Metformin Fixed-Dose Combination and Corresponding Individual Components in Healthy Chinese Male and Female Subjects
    Liu, Chao
    Cleton, Adriaan
    Sui, Yubin
    Liu, Yuwang
    Li, Jinyi
    Yuan, Fei
    Sheng, Lei
    Xu, Hongrong
    Li, Xuening
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (02): : 173 - 184
  • [48] Pharmacodynamic effects of voglibose administered alone, administered with metformin, and administered with metformin in a fixed-dose combination in healthy Korean subjects
    Kim, Ho-Sook
    Oh, Minkyung
    Kim, Eun Ji
    Song, Geun Seog
    Kim, Eun-young
    Shin, Jae-Gook
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (11) : 544 - 550
  • [49] PHARMACOKINETICS AND PHARMACODYNAMICS OF A FIXED-DOSE COMBINATION OF GEMIGLIPTIN AND METFORMIN COMPARED TO LOOSE COMBINATION IN HEALTHY SUBJECTS.
    Jin, X.
    Kim, E.
    Rhee, S. -J.
    Hwang, I.
    Kim, Y.
    Lee, H.
    Yu, K. -S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S100 - S100
  • [50] BIOEQUIVALENCE OF METFORMIN IN ERTUGLIFLOZIN/METFORMIN FIXED DOSE COMBINATION TABLETS TO CANADIAN-SOURCED METFORMIN CO-ADMINISTERED WITH ERTUGLIFLOZIN UNDER FASTED AND FED STATES.
    Kumar, V.
    Liang, Y.
    Pelletier, K.
    Matschke, K.
    Shi, H.
    Hickman, A.
    Bass, A.
    Zhou, S.
    Krishna, R.
    Sahasrabudhe, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S75 - S75
12345